We recently published 10 Stocks Beating the Market with Eye-Popping Gains. 10x Genomics Inc. (NASDAQ:TXG) is one of the best-performing stocks on Monday. Shares of 10x Genomics propelled to a new ...
Oct 21 (Reuters) - Biotech company 10x Genomics (TXG.O), opens new tab filed two lawsuits against rival Illumina (ILMN.O), opens new tab in Delaware federal court on ...
SPT Labtech and 10x Genomics have partnered to provide automated workflows for single cell research. The collaboration will allow scientists to scale experiments on 10x’s Chromium Single Cell platform ...
For content to make a real impact, it can no longer just be better—it has to be exponentially better. Search results are saturated, readers are increasingly skeptical, and Google is heavily ...
10x Genomics is stepping up to buy Scale Biosciences and its single-cell profiling solutions, with plans to implement them within the company’s Chromium platform. The deal for the recent Fierce ...
10x Genomics is bolstering its commitment to scaling single cell experiments through the acquisition of Scale Biosciences. 10x has agreed to pay $30 million in cash and stock upfront, plus an ...
The CorelDRAW Graphic Suite 2025 is an excellent and decently priced bundle of applications for your Mac or PC. The tools are powerful, and simple to use - once you’ve acquainted yourself with the ...
Serge Saxonov emphasizes that what defines 10x Genomics is the talent of its employees. The founders all hold PhDs and that’s the educational level of many of their employees. It’s also ...
My husband left me at 60 to have a baby with a younger woman. Here's what it taught me. Trump quips about seeking DOJ settlement: 'I hereby give myself $1 billion' Swedish actress May Britt, former ...
Alludo has launched new updates to its popular CorelDRAW Graphics Suite 2024 and CorelDRAW Technical Suite. The updates include a range of enhancements such as Vector FX, Painterly Brush tool and new ...
10x Genomics (TXG) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates - ...